Rep. Jared Moskowitz Buys Shares of Stryker Co. (NYSE:SYK)

Representative Jared Moskowitz (D-Florida) recently bought shares of Stryker Co. NYSE: SYK. In a filing disclosed on May 09th, the Representative disclosed that they had bought between $1,001 and $15,000 in Stryker stock on April 7th. The trade occurred in the Representative's "MORGAN STANLEY ACTIVE ASSETS (1)" account.

Representative Jared Moskowitz also recently made the following trade(s):

• Purchased $1,001 - $15,000 in shares of Amgen NASDAQ: AMGN on 4/16/2025.
• Purchased $1,001 - $15,000 in shares of NVIDIA NASDAQ: NVDA on 4/16/2025.
• Sold $1,001 - $15,000 in shares of Starbucks NASDAQ: SBUX on 4/10/2025.
• Sold $15,001 - $50,000 in shares of The Goldman Sachs Group NYSE: GS on 4/10/2025.
• Sold $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 4/10/2025.
• Purchased $1,001 - $15,000 in shares of Southern NYSE: SO on 4/7/2025.
• Purchased $1,001 - $15,000 in shares of AbbVie NYSE: ABBV on 4/7/2025.
• Purchased $1,001 - $15,000 in shares of Sherwin-Williams NYSE: SHW on 4/7/2025.
• Purchased $1,001 - $15,000 in shares of Texas Instruments NASDAQ: TXN on 4/7/2025.
• Purchased $1,001 - $15,000 in shares of Amazon.com NASDAQ: AMZN on 4/7/2025.

Stryker Trading Up 1.6%

NYSE SYK traded up $6.10 during trading on Thursday, hitting $392.42. The stock had a trading volume of 1,124,420 shares, compared to its average volume of 1,347,156. Stryker Co. has a one year low of $314.93 and a one year high of $406.19. The stock has a 50 day simple moving average of $365.58 and a 200 day simple moving average of $374.90. The stock has a market capitalization of $149.78 billion, a price-to-earnings ratio of 50.57, a P/E/G ratio of 2.93 and a beta of 0.93. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95.

Stryker (NYSE:SYK - Get Free Report) last released its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The business had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The business's revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the firm posted $2.50 earnings per share. Sell-side analysts predict that Stryker Co. will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be given a $0.84 dividend. This represents a $3.36 dividend on an annualized basis and a yield of 0.86%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio (DPR) is currently 45.41%.

Hedge Funds Weigh In On Stryker

Hedge funds and other institutional investors have recently bought and sold shares of the business. Kohmann Bosshard Financial Services LLC acquired a new stake in Stryker during the fourth quarter worth about $25,000. Capital A Wealth Management LLC acquired a new stake in shares of Stryker during the 4th quarter worth approximately $26,000. Rakuten Securities Inc. grew its stake in shares of Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares during the period. Centricity Wealth Management LLC acquired a new position in shares of Stryker in the 4th quarter valued at $30,000. Finally, Goodman Advisory Group LLC acquired a new position in shares of Stryker in the 1st quarter valued at $32,000. Institutional investors and hedge funds own 77.09% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently issued reports on the company. Evercore ISI dropped their price objective on Stryker from $400.00 to $390.00 and set an "outperform" rating on the stock in a research note on Friday, May 2nd. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a research report on Monday, May 5th. Citigroup restated a "buy" rating and set a $450.00 price objective on shares of Stryker in a research note on Wednesday, February 26th. Stifel Nicolaus lifted their target price on Stryker from $400.00 to $440.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. Finally, Sanford C. Bernstein set a $450.00 price target on shares of Stryker in a research report on Monday, May 5th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $427.05.

Insider Buying and Selling

In other Stryker news, Director Allan C. Golston sold 2,458 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The stock was sold at an average price of $383.07, for a total transaction of $941,586.06. Following the completion of the sale, the director now directly owns 14,895 shares in the company, valued at approximately $5,705,827.65. The trade was a 14.16% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total value of $75,392,000.00. Following the completion of the transaction, the director now owns 3,417,326 shares in the company, valued at approximately $1,288,195,208.96. This trade represents a 5.53% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by insiders.

About Representative Moskowitz

Jared Evan Moskowitz (Democratic Party) is a member of the U.S. House, representing Florida's 23rd Congressional District. He assumed office on January 3, 2023. His current term ends on January 3, 2027. Moskowitz (Democratic Party) is running for re-election to the U.S. House to represent Florida's 23rd Congressional District. He declared candidacy for the 2026 election. Jared Evan Moskowitz was born in Coral Springs, Florida. Moskowitz graduated from Marjory Stoneman Douglas High School. He earned a bachelor's degree in political science and government from George Washington University in 2003 and a law degree from Nova Southeastern University in 2007. Moskowitz's career experience includes working as the director of the Florida Division of Emergency Management and general counsel with AshBritt Inc.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.